Idexx Laboratories Inc (IDXX)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Idexx Laboratories Inc (IDXX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014358
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Idexx Laboratories Inc (IDEXX) is a diagnostics company. It develops, manufactures and distributes products and services for small animals and livestock. The company offers veterinary reference laboratory diagnostics and consulting services, point-of-care veterinary diagnostic products, microbiological contaminant testing products (in water), livestock and poultry diagnostic and health-monitoring products, antibiotic residue testing products (in milk), and practice management systems and services. IDEXX also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. The company offers its products to veterinary, equine, livestock and poultry, water testing and dairy markets. It operates in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. IDEXX is headquartered in Westbrook, Maine, the US.

Idexx Laboratories Inc (IDXX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Idexx Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Idexx Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 8
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Idexx Labs Enters Into Licensing Agreement With Exiqon For Locked Nucleic Acids Technology 10
Debt Offering 11
Idexx Labs Completes Private Placement Of Series B Notes Due 2025 For US$75 Million 11
Idexx Labs Completes Private Placement Of Series A Notes Due 2023 For US$75 Million 12
Idexx Laboratories Inc – Key Competitors 13
Idexx Laboratories Inc – Key Employees 14
Idexx Laboratories Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 18
Financial Announcements 18
Oct 31, 2017: IDEXX Laboratories Announces Third Quarter Results 18
Apr 28, 2017: IDEXX Laboratories Announces First Quarter Results-2017 20
Apr 29, 2016: IDEXX Laboratories Announces First Quarter Results 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Idexx Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Idexx Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 8
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Idexx Labs Enters Into Licensing Agreement With Exiqon For Locked Nucleic Acids Technology 10
Idexx Labs Completes Private Placement Of Series B Notes Due 2025 For US$75 Million 11
Idexx Labs Completes Private Placement Of Series A Notes Due 2023 For US$75 Million 12
Idexx Laboratories Inc, Key Competitors 13
Idexx Laboratories Inc, Key Employees 14
Idexx Laboratories Inc, Other Locations 15
Idexx Laboratories Inc, Subsidiaries 15

★海外企業調査レポート[Idexx Laboratories Inc (IDXX)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Innergex Renewable Energy Inc (INE):企業の財務・戦略的SWOT分析
    Innergex Renewable Energy Inc (INE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Strides Pharma Science Limited (STAR):医療機器:M&Aディール及び事業提携情報
    Summary Strides Pharma Science Limited (Strides Pharma), formerly Strides Shasun Ltd, is a pharmaceutical company which offers generic products. It focuses on the development and manufacture of intellectual property- led niche pharmaceutical products, over-the-counter drugs and nutraceuticals. The c …
  • SPX Corporation:企業の戦略・SWOT・財務情報
    SPX Corporation - Strategy, SWOT and Corporate Finance Report Summary SPX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • The Eat Out Group, SL:企業の戦略・SWOT・財務情報
    The Eat Out Group, SL - Strategy, SWOT and Corporate Finance Report Summary The Eat Out Group, SL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sims Metal Management Ltd:企業の戦略・SWOT・財務分析
    Sims Metal Management Ltd - Strategy, SWOT and Corporate Finance Report Summary Sims Metal Management Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • MagForce AG (MF6):企業の財務・戦略的SWOT分析
    Summary MagForce AG (MagForce) is a medical device company that offers nanotechnology-based therapy for cancer treatment. The company’s products include NanoActivator, NanoTherm, NanoPlan and NanoTherm Therapy. Its NanoActivator creates a magnetic field that can be used to treat tumors in all areas …
  • Cadence Design Systems, Inc. (CDNS):企業の財務・戦略的SWOT分析
    Cadence Design Systems, Inc. (CDNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Changmao Biochemical Engineering Co., Ltd:企業の戦略・SWOT・財務情報
    Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Bausch & Lomb Inc:企業の戦略的SWOT分析
    Bausch & Lomb Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • The National Petrochemical Co:企業の戦略的SWOT分析
    The National Petrochemical Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Pathogenetix Inc-医療機器分野:企業M&A・提携分析
    Summary Pathogenetix Inc (Pathogenetix), formerly US Genomics, a subsidiary of Toxic Reports LLC is a medical device company that develops an automated system for bacterial strain typing from complex samples. The company develops products and applications based on its proprietary genome sequence sca …
  • Olympus Corp (7733):医療機器:M&Aディール及び事業提携情報
    Summary Olympus Corporation (Olympus) provides precision machinery and instruments. It develops, manufactures and markets equipment and devices for medical, healthcare, imaging, information, and other industrial markets. It offers medical systems such as endotherapy devices, medical endoscopes and t …
  • Adverum Biotechnologies Inc (ADVM):企業の財務・戦略的SWOT分析
    Summary Adverum Biotechnologies Inc (Adverum), formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-rela …
  • Institute of Cancer Research-製薬・医療分野:企業M&A・提携分析
    Summary Institute of Cancer Research (ICR), a subsidiary of University of London is a research institute that offers cancer research and education programs. The institute conducts research and develops new therapies for the treatment of cancer including breast and lung cancer. It offers various post …
  • SNC-Lavalin Group Inc (SNC)-エネルギー分野:企業M&A・提携分析
    Summary SNC-Lavalin Group Inc. (SNC) is global provider of engineering and construction services. It offers a range of engineering, procurement, construction, project management services to various industries, including oil and gas, mining and metallurgy, infrastructure and power. In addition, the c …
  • Sorrento Therapeutics, Inc.:企業のM&A・事業提携・投資動向
    Sorrento Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sorrento Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Kotra Industries Berhad (KOTRA):企業の財務・戦略的SWOT分析
    Kotra Industries Berhad (KOTRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • ComfortDelGro Corporation Limited:戦略・SWOT・企業財務分析
    ComfortDelGro Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary ComfortDelGro Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Medicenna Therapeutics Corp (MDNA)-製薬・医療分野:企業M&A・提携分析
    Summary Medicenna Therapeutics Corp (Medicenna) formerly known as A2 Acquisition Corp, is a clinical stage, immuno-oncology company which provides novel first-in-class and interleukin-4 empowered cytokines. The Company's products under development include MDNA55, MDNA56, MDNA57, fully human interleu …
  • Sumitomo Mitsui Banking Corp:企業のM&A・事業提携・投資動向
    Sumitomo Mitsui Banking Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sumitomo Mitsui Banking Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆